Vitrolife AB
STO:VITR
Vitrolife AB
STO:VITR
Price:
181.1 SEK
-1.36%
Market Closed
Updated:
Jun 9, 2024
Vitrolife AB
Operating Expenses
|
Vitrolife AB
Operating Expenses Peer Comparison
Comparables:
BIOG B
HNSA
BONEX
SOBI
BIOA B
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vitrolife AB
STO:VITR
|
Operating Expenses
-kr5.6B
|
CAGR 3-Years
-142%
|
CAGR 5-Years
-71%
|
CAGR 10-Years
-38%
|
|
|
Biogaia AB
STO:BIOG B
|
Operating Expenses
-kr508.9m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Hansa Biopharma AB
STO:HNSA
|
Operating Expenses
-kr854.1m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-48%
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Operating Expenses
-kr557.9m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Operating Expenses
-kr13.3B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-23%
|
|
|
BioArctic AB
STO:BIOA B
|
Operating Expenses
-kr300.5m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
See Also
What is Vitrolife AB's Operating Expenses?
Operating Expenses
-5.6B
SEK
-5.6B
SEK
Based on the financial report for Mar 31, 2024, Vitrolife AB's Operating Expenses amounts to -5.6B SEK.
What is Vitrolife AB's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-38%
-38%
Over the last year, the Operating Expenses growth was -376%. The average annual Operating Expenses growth rates for Vitrolife AB have been -142% over the past three years , -71% over the past five years , and -38% over the past ten years .
You don't have any saved screeners yet
